Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Stock Analysis
Stock Analysis provides insights into evaluating companies and their potential for growth. Understanding stock trends is crucial for making smart investment choices.
663 articles
Million Arcellx Sale Follows Stock Drop as Rival Emerges
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
Celcuity Stock Soars 700% After Major Investor Buy
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Cognex Stock Sell After Director Dump: Buy or Sell?
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
ExxonMobil Stock Surged January: Drivers and Focus
ExxonMobil stock surged January as energy markets moved higher, but the real story runs deeper than a single month. T...
This "magnificent Seven" Stock Down 22%: Buy Before Breakout
One member of the famous seven has slipped 22% from its high. This article outlines whether the drop is a buying sign...
Teladoc Stock Going Ready for a Comeback This Year?
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
Stock Falling Knife? Is FMC Stock a Buy Now or Not?
FMC stock has seen a sharp drop, prompting questions about value and timing. This guide breaks down how to tell if th...
Walmart Amazon: Which Trillion-Dollar Stock Is a Better Buy
Two retail giants, two very different paths to trillion-dollar status. This guide breaks down the case for Walmart an...
Palantir Buy, Sell, Hold Outlook for 2026 and Beyond
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
Whetstone Dumps 79,000 Monday.com Shares: What It Means
When a prominent hedge fund reports selling a large block of shares, it sparks questions about the stock’s future. Th...
What’s Wrong with UnitedHealth Stock? A Real-World Analysis
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...